[Present status of clinical researches on the screening for prostate cancer biomarkers].
Researches on the biomarkers of tumors are very important for their early diagnosis and treatment. Although PSA has been used for over 20 years for screening prostate cancer and evaluating its treatment, the results are not entirely satisfactory. With the deepening of the researches on prostate cancer, a variety of prostate cancer biomarkers have been found. This article presents an overview on the recent advances in the screening for prostate cancer biomarkers.